Allen R. Nissenson
Board Member
Elicio Therapeutics, Inc. (ELTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Allen R. Nissenson
Allen R. Nissenson is recorded as Board Member at Elicio Therapeutics, Inc. (ELTX). Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Allen R. Nissenson was appointed Class I Director, effective June 1, 2023.
“Robert Connelly, Yekaterina (Katie) Chudnovsky and Allen R. Nissenson, M.D. being appointed as Class I directors of the Company whose terms expire at the Company's 2024 annual meeting of stockholders”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
- Jay R. Venkatesan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.